ArticleFrontiers in oncology2022

Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer.

Thais Baccili Cury Megid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.